Enovis ENOV United States — Net Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Enovis in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Enovis’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Enovis's united states — net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Enovis's united states — net sales?
- Enovis (ENOV) reported united states — net sales of $323.83M in Q4 2025.
- How has Enovis's united states — net sales changed year-over-year?
- Enovis's united states — net sales increased by 4.0% year-over-year, from $311.42M to $323.83M.
- What is the long-term trend for Enovis's united states — net sales?
- Over 4 years (2021 to 2025), Enovis's united states — net sales has grown at a 5.9% compound annual growth rate (CAGR), from $1.03B to $1.3B.
- What does united states — net sales mean?
- This metric represents the total revenue generated from the sale of medical devices and clinical solutions within the United States geographic market. It serves as a primary indicator of the company's market penetration, demand for its reconstructive and rehabilitation products, and overall commercial success in its largest operating region. Tracking this figure helps investors assess regional growth trends and the effectiveness of local sales and distribution strategies.